Correction Volume 15, Issue 20 pp 11690—11691

Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen

Liang Wang1, *, , Yinfeng Lyu2, *, , Yuqing Li2, , Kunping Li2, , Hui Wen2, , Chenchen Feng2, , Ning Li3, ,

  • 1 Department of Urology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
  • 2 Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China
  • 3 Department of Urology, Fourth Affiliated Hospital of China Medical University, Shenyang 100032, Liaoning Province, P.R. China
* Equal contribution

Received: October 16, 2023       Accepted: October 27, 2023       Published: October 30, 2023      

https://doi.org/10.18632/aging.205255
How to Cite
Correction for: Aging (Albany NY). 2021; 13:22286-22297 . https://doi.org/10.18632/aging.203534  PMID: 34536950

Copyright: © 2023 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.